Mayne Pharma began construction on a new $65-million pharmaceutical manufacturing facility in Greenville, NC. The 126,000-sq.-ft., oral-dose facility will more than double the company’s U.S. manufacturing capacity. Also, the re-purposing of space within the existing facility will significantly expand capacity for contract analytical lab and formulation development services with more than 10 new processing rooms and expanded labs.    The new facility will house commercial manufacturing and pack...